Committee for Pharmaceutical Development (CPD)
The goal of the Committee for Pharmaceutical Development (CPD) is to identify, develop, and commercialize pharmaceutical products by forming networks and fostering dialogue between University of Minnesota researchers and industry experts.
The CPD aims to boost the success rate of therapeutic development and commercialization.
The CPD includes University staff and external advisors with proven drug-development experience.
The CPD provides guidance and funding, with potential matching funds from philanthropic and industry partners. Funded technologies will have demonstrated persuasive indicators of commercial success and will show potential for improving human health.
Learn more about the types of projects we prioritize.
Awardees
2019
James M. Ervasti, PhD, and David D. Thomas, PhD, and Joseph M. Muretta, PhD, Department of Biochemistry, Molecular Biology and Biophysics, Medical School
Project title: Mini-/Micro-Dystrophin Actin Binding Domain 1 Gain-of-Affinity
2018
Jon Hawkinson, PhD, Institute for Therapeutics Discovery & Development
Project title: Critical path studies to nominate BINTA as a preclinical development candidate to treat chronic pain devoid of opioid side effect liability
2016
George Wilcox, Daniel Bruce, Philip Portoghese, and Carolyn Fairbanks
Project title: Peripherally restricted combination therapy for inflammatory or cancer-related chronic pain
2015
Gwenyth Fischer, MD, Medical School, Department of Pediatrics
Project title: Epinephrine Drug-delivery Device for use in Pediatric Cardiac Arrest
Amber Lockridge, Medical School, Department of Neuroscience
Project title: The Use of D-serine as a Novel Insulin Secretagogue and Oral Antidiabetic
2014
Gregory Beilman, MD, Medical School, Department of Surgery
Project title: Beta-hydroxybutyrate/melatonin (BHB/M) for the Treatment of Trauma-induced Acute Blood Loss
Lester Drewes, PhD, Medical School, Department of Biomedical Sciences, and Venkatram Mereddy, PhD, College of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences
Project title: Development of Novel Drugs for High Risk Triple Negative Breast Cancer Treatment
Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics
Project title: Antibody Targeting Metastases in triple Negative Breast Cancer
2013
Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics
Project title: Surface Functionalized Nanoparticles for Improved Chemotherapeutic Efficacy
Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics
Project title: Silicate Prodrug Nanoparticles of Paclitaxel
Chun Wang, PhD, College of Science and Engineering, Department of Biomedical Engineering
Project title: Semi-solid Polymer Delivery Systems for Immunotherapy against Melanoma
2012
Daniel Vallera, PhD, Medical School, Department of Radiation Oncology
Project title: Developing Biological Drugs Targeting Chemo-Refractory Carcinoma
Carston R. Wagner, PhD, College of Pharmacy, Department of Medicinal Chemistry
Project title: In vivo Proof-of-Concept Studies on Chemically Self Assembled Nanostructures (CSANS) as Targeted Diagnostic Imaging and Drug Delivery agents for Brain Cancer
Apply now
Applications are accepted on a continuous basis. Please submit forms to the Program Manager at fenl0003@umn.edu.
Contact us
Sandra M. Wells, Ph.D.
Assistant Director
smwells@umn.edu
612-625-3073
Jodi Fenlon Rebuffoni
Project Manager
Office of Discovery and Translation
fenl0003@umn.edu
612-626-6945
Grantee spotlight
CTSI helps a potentially life-saving treatment advance closer to clinical trials
